| Description | Mazorelvimab (SYN023), a cocktail composed of the humanized monoclonal antibodies CTB011 and CTB012, targets the rabies virus (RABV) by binding to non-overlapping epitopes on the RABV's glycoprotein (G). This interaction showcases Mazorelvimab's potential in rabies prevention [1] [2]. |
| molecular weight | N/A |
| CAS | 2419087-89-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 years |